IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamilton, A.
Right arrow Articles by Jones, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamilton, A.
Right arrow Articles by Jones, A. L.
Infection and Immunity, November 2006, p. 6179-6187, Vol. 74, No. 11
0019-9567/06/$08.00+0     doi:10.1128/IAI.00895-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Penicillin-Binding Protein 1a Promotes Resistance of Group B Streptococcus to Antimicrobial Peptides

Andrea Hamilton,1 David L. Popham,2 David J. Carl,1 Xavier Lauth,3,{dagger} Victor Nizet,3 and Amanda L. Jones1*

Department of Pediatrics, University of Washington, Seattle, Washington,1 Department of Biological Sciences, Virginia Tech, Blacksburg, Virginia,2 Department of Pediatrics, University of California, San Diego, La Jolla, California3

Received 6 June 2006/ Returned for modification 21 July 2006/ Accepted 4 August 2006

Evasion of host immune defenses is critical for the progression of invasive infections caused by the leading neonatal pathogen, group B streptococcus (GBS). Upon characterizing the factors required for virulence in a neonatal rat sepsis model, we found that a surface-associated penicillin-binding protein (PBP1a), encoded by ponA, played an essential role in resistance of GBS to phagocytic clearance. In order to elucidate how PBP1a promotes resistance to innate immunity, we compared the susceptibility of wild-type GBS and an isogenic ponA mutant to the bactericidal components of human neutrophils. The isogenic strains were found to be equally capable of blocking complement activation on the bacterial surface and equally associated with phagocytes and susceptible to oxidative killing. In contrast, the ponA mutant was significantly more susceptible to killing by cationic antimicrobial peptides (AMPs) of the cathelicidin and defensin families, which are now recognized as integral components of innate host defense against invasive bacterial infection. These observations may help explain the sensitivity to phagocytic killing and attenuated virulence of the ponA mutant. This novel function for PBP1a in promoting resistance of GBS to AMP did not involve an alteration in bacterial surface charge or peptidoglycan cross-linking. While the peptidoglycan polymerization and cross-linking activity of PBPs are essential for bacterial survival, our study is the first to identify a role for a PBP in resistance to host AMPs.


* Corresponding author. Mailing address: Children's Hospital and Regional Medical Center, 307 Westlake Ave. N, Suite 300, Seattle, WA 98109. Phone: (206) 987-3573. Fax: (206) 987-7311. E-mail: amanda.jones{at}seattlechildrens.org.

Editor: J. N. Weiser

{dagger} Present address: Kent SeaTech and Aquabounty Pacific, San Diego, CA.


Infection and Immunity, November 2006, p. 6179-6187, Vol. 74, No. 11
0019-9567/06/$08.00+0     doi:10.1128/IAI.00895-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2006 by the American Society for Microbiology. All rights reserved.